Tuberculosis Demonstration, Research, Public and Professional Education

 

To assist States, political subdivisions of States, and other public and nonprofit private entities in conducting research into prevention and control of tuberculosis (TB) nationally and internationally. To conduct demonstration projects, provide TB and latent TB infections (LTBI) communication, education, training, medical consultation activities to TB programs, private providers, and other partners for the prevention and control of TB.

Active 93.947 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. This program is authorized under Sections 317(k)(2), 317E and 318c of the Public Health Service Act (42 U.S.C. Sections 247b-6 and 247c ), as amended. 42 U.S.C. Section 287b, 31 U.S.C. 6305, and 42 CFR 63a States, political subdivisions of States, and other public and nonprofit private entities. States, political subdivisions of States, other public and nonprofit private entities, serving persons with TB infection and disease. Not applicable. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After officials review and approve applications, a notice of award (NoA) is prepared and processed, and appropriate notification is made to the public. Initial award provides funds for the first budget period (12 months) and NoA indicates support provided in the initial award and the recommended funding amounts for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. From 60 to 90 days. Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. All applications will be reviewed initially for completeness by CDC. Incomplete applications that do not meet the eligibility criteria will not advance. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the notice of funding opportunity (NOFO). Requests for direct assistance (i.e., "in lieu of cash") for personnel, equipment, and supplies directly related to project activities, particularly directly observed therapy, patient outreach, and program assessment will be considered. Project funds may not be used to supplant State or local funds available for tuberculosis control or to support construction costs or inpatient care. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Megan B. Copeland
1600 Clifton Road, MS E-07
Atlanta, GA 30096 US
mzf3@cdc.gov
Phone: 4046398864 http://www.cdc.gov/tb 75-0950-0-1-550 (Cooperative Agreements) FY 22$6,856,323.00; FY 23 est $5,328,040.00; FY 24 est $5,328,040.00; - $665,000 to $1,328,000 with an average of $1,104,000. Not applicable. Not applicable.